Why is ANG Lifesciences falling/rising?

As of 26-Sep, ANG Lifesciences India Ltd is experiencing a decline in its stock price, currently at Rs 33.57, which represents a decrease of -1.71 (-4.85%). The stock has underperformed its sector by -2.65% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of -6.66%. The stock opened with a loss of -2.01% and reached an intraday low of Rs 33.52. Over the past week, the stock has fallen by -1.64%, while it has shown a positive return of +15.28% over the past month. However, the company's financial health is concerning, with reported operating losses and a high Debt to EBITDA ratio of 5.83 times, contributing to a negative return on equity. The company has declared negative results for the last 12 consecutive quarters, with significant declines in net sales and profits, which further exacerbates investor sentiment.
In the broader market context, the stock's performance is contrasted with the Sensex, which has decreased by -2.66% over the past week. Despite the stock's recent positive return over the month, it has consistently underperformed against the benchmark over the last three years, generating -34.09% returns in the past year compared to the Sensex's +2.93% year-to-date performance. The pharmaceuticals and drugs sector has also seen a decline of -2.35%, indicating a challenging environment. Additionally, a significant portion of promoter shares (44.88%) is pledged, which can exert further downward pressure on the stock price in a declining market. Overall, the combination of weak financial fundamentals, negative investor sentiment, and broader market challenges are contributing to the stock's current downward trajectory.